Table 2.
VET studies in liver transplant describing parameters for hemostatic interventions
Study | Study type | N | MELD (median) | Device | Reagents and/or test | Assay inflection points for interventions: | |||
---|---|---|---|---|---|---|---|---|---|
Plasma | Cryoprecipitate/Fibrinogen | Platelets | Antifibrinolytic | ||||||
Trzebicki et al38 | Observational | 39 | 17 | ROTEM Delta | EXTEM, FIBTEM | Clotting time with EXTEM > 90 min | MCF with FIBTEM < 10 | MCF with EXTEM < 50 | Maximum lysis > 15% |
Wang et al26 | Randomized controlled trial | 28 | 11 | TEG 5000 | Kaolin | Reaction time > 10 min | Angle <45° | Maximum amplitude < 50 mm | None reported |
Roullet et al39 | Observational | 60 | 19 | ROTEM Delta | EXTEM, FIBTEM | Not reported | Amplitude at 10 min with EXTEM < 26 mm; amplitude at 10 min with EXTEM ≥ 29 mm and with FIBTEM ≤ 8 mm | Amplitude at 10 min with EXTEM < 26 mm and with FIBTEM > 8 mm | “Hyperfibrinolysis present” with EXTEM or FIBTEM |
De Pietri et al23 | Observational | 386 | 20 | TEG 5000 | Native, FF | Reaction time > 40 min and maximum amplitude with FF > 7 mm | Maximum amplitude < 30 mm and maximum amplitude with FF < 7 mm | Maximum amplitude < 30mm and maximum amplitude with FF > 7 mm | “Fibrinolysis present” |
Smart et al28 | Observational | 68 | 28 | ROTEM Delta | EXTEM, FIBTEM | Clotting time with EXTEM > 90 min | MCF with FIBTEM < 10 | MCF with EXTEM < 50 | Maximum lysis with EXTEM > 15% |
Zamper et al27 | Propensity matched | 237 | 22 | ROTEM Delta | INTEM, HEPTEM, EXTEM, FIBTEM | Clotting time with INTEM > 240 min and clotting time with HEPTEM ≥ clotting time with INTEM | Amplitude at 5 min with EXTEM < 25 mm and amplitude at 10 min with FIBTEM < 10 mm | Amplitude at 5 min with EXTEM < 25 mm and amplitude at 10 min with FIBTEM > 10 mm | Clot lysis index at 30 min with EXTEM < 50% after reperfusion |
Bonnet et al25 | Randomized controlled trial | 81 | 16 | ROTEM Delta | EXTEM, APTEM | Clotting time with EXTEM > 110 min | Amplitude at 10 min with FIBTEM < 10 mm | MCF with EXTEM < 40 mm or amplitude at 10 min < 35 mm and amplitude at 10 min with FIBTEM > 8 mm or MCF > 8 mm | Hyperfibrinolysis with EXTEM or maximum lysis < 15% and with APTEM < 10% clotting time or clot formation time > 15% MCF |
Scarlatescu et al29 | Propensity matched | 188 | 19 | ROTEM Delta | INTEM, HEPTEM, EXTEM, FIBTEM | Clotting time with INTEM > 280 min and clotting time with HEPTEM > 280 min | Amplitude at 10 min EXTEM < 25 mm and amplitude at 10 min FIBTEM < 8 mm | Amplitude at 10 min with EXTEM < 25 mm and amplitude at 10 min with FIBTEM > 8 mm | Clot lysis index at 60 min EXTEM < 85% in pre-anhepatic phase or clot lysis index at 30 min with EXTEM < 50% anhepatic phase or later |
Gaspari et al40 | Propensity matched | 226 | 20 | TEG 5000 | Kaolin | Not reported | Angle < 55° | Maximum amplitude < 30 mm | Not reported |
Abbreviations: FF, functional fibrinogen; MELD, Model for End-Stage Liver Disease score; N, population number; ROTEM, rotational thrombelastography; TEG, thrombelastography; VET, viscoelastic testing.